Education
About Us
Working with TipRanks
Follow Us
Hepion Pharmaceuticals (HEPA)
NASDAQ:HEPA
Total Valuation
Hepion Pharmaceuticals has a market cap or net worth of $3.54M. The enterprise value is ―.
Market Cap$3.54M
Enterprise Value―
Share Statistics
Hepion Pharmaceuticals has 10,927,279 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding10,927,279
Owned by Insiders0.18%
Owned by Institutions2.18%
Financial Efficiency
Hepion Pharmaceuticals’s return on equity (ROE) is 7.08 and return on invested capital (ROIC) is -1671.79%.
Return on Equity (ROE)7.08
Return on Assets (ROA)-8.18
Return on Invested Capital (ROIC)-1671.79%
Return on Capital Employed (ROCE)12.64
Revenue Per Employee0.00
Profits Per Employee-599.66K
Employee Count22
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Hepion Pharmaceuticals is -0.22. Hepion Pharmaceuticals’s PEG ratio is >-0.01.
PE Ratio-0.22
PS Ratio0.00
PB Ratio-1.55
Price to Fair Value-1.55
Price to FCF-0.16
Price to Operating Cash Flow-0.16
PEG Ratio>-0.01
Income Statement
In the last 12 months, Hepion Pharmaceuticals had revenue of 0.00 and earned -13.19M in profits. Earnings per share was -107.35.
Revenue0.00
Gross Profit0.00
Operating Income-19.35M
Pretax Income-16.16M
Net Income-13.19M
EBITDA-19.35M
Earnings Per Share (EPS)-107.35
Cash Flow
In the last 12 months, operating cash flow was -18.22M and capital expenditures 0.00, giving a free cash flow of -18.22M billion.
Operating Cash Flow-18.22M
Free Cash Flow-18.22M
Free Cash Flow per Share-1.67
Dividends & Yields
Hepion Pharmaceuticals pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.24
52-Week Price Change-99.40%
50-Day Moving Average1.51
200-Day Moving Average21.98
Relative Strength Index (RSI)29.09
Average Volume (3m)7.80M
Important Dates
Hepion Pharmaceuticals upcoming earnings date is May 15, 2018, TBA Not Confirmed.
Last Earnings DateInvalid Date
Next Earnings DateMay 15, 2018
Ex-Dividend Date―
Financial Position
Hepion Pharmaceuticals as a current ratio of 0.51, with Debt / Equity ratio of -155.63%
Current Ratio0.51
Quick Ratio0.51
Debt to Market Cap1.00
Net Debt to EBITDA-0.13
Interest Coverage Ratio15.51
Taxes
In the past 12 months, Hepion Pharmaceuticals has paid 2.97M in taxes.
Income Tax2.97M
Effective Tax Rate-0.18
Enterprise Valuation
Hepion Pharmaceuticals EV to EBITDA ratio is -0.28, with an EV/FCF ratio of -0.30.
EV to Sales0.00
EV to EBITDA-0.28
EV to Free Cash Flow-0.30
EV to Operating Cash Flow-0.30
Balance Sheet
Hepion Pharmaceuticals has $406.41K in cash and marketable securities with $2.90M in debt, giving a net cash position of $2.49M billion.
Cash & Marketable Securities$406.41K
Total Debt$2.90M
Net Cash$2.49M
Net Cash Per Share$0.23
Tangible Book Value Per Share-$15.16
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Hepion Pharmaceuticals is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―